eBooks Press Release -- NEWS
Bentham's Latest Book: Frontiers in Cardiovascular Drug Discovery - Vol. 4
News Release Date: April 26, 2019
This book is Edited by: Dr. Atta-ur-Rahman and Dr. M. Iqbal Choudhary, Published on: April 05, 2019.
Frontiers in Cardiovascular Drug Discovery is an eBook series devoted to publishing the latest advances in cardiovascular drug design and discovery. Each volume brings reviews on the biochemistry, in-silico drug design, combinatorial chemistry, high-throughput screening, drug targets, recent important patents, and structure-activity relationships of molecules used in cardiovascular therapy. The eBook series should prove to be of great interest to all medicinal chemists and pharmaceutical scientists involved in preclinical and clinical research in cardiology.
The fourth volume of the series covers the following topics:
About the Author:
Atta-ur-Rahman, Ph.D. in organic chemistry from Cambridge University (1968), has 1142 international publications in several fields of organic chemistry including 775 research publications, 43 international patents, 70 chapters in books and 253 books published largely by major U.S. and European presses. He is the Editor-in-Chief of eight European Chemistry journals. He is Editor of the world's leading encyclopedic series of volumes on natural products "Studies in Natural Product Chemistry" 60 volumes of which have been published under his Editorship by Elsevier during the last two decades.
M. Iqbal Choudhary
M. Iqbal Choudhary is a Ph. D. scientist in the field of organic chemistry from Pakistan working at the University of Karachi. He is known for his research in bioorganic chemistry and natural product chemistry. He has more than 900 research publications, including 32 books published.
Keywords: Essential Thrombocythemia, Platelet Reactivity, Adenosine receptors, Allosteric modulators, Receptor dimerization, Platelet Activity Stenting, Dual Antiplatelet Therapy, Clopidogrel Withdrawal, Heart transplantation, Immunosuppression, pharmacotherapy, Alirocumab, Evolocumab, Familial hypercholesterolemia, medicinal chemistry, cardiology.